SPARC is up-regulated during skeletal muscle regeneration and inhibits myoblast differentiation

Histology and Histopathology

Volumn 28, Issue 11, 2013, Pages 1451-1460

  Petersson, Stine Juhl ^a,b   Jørgensen, Louise Helskov ^a   Andersen, Ditte C ^a,b   Nørgaard, Rikke C ^a   Jensen, Charlotte Harken ^a,b   Schrøder, Henrik Daa ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Myoblasts; Myogenic differentiation; Regeneration; Skeletal muscle; SPARC osteonectin BM 40

Indexed keywords

OSTEONECTIN; SPARC PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MYOBLAST; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MICE; MUSCLE, SKELETAL; MYOBLASTS; OSTEONECTIN; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TRANSFECTION; UP-REGULATION;

EID: 84886287814     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Alford A.I. and Hankenson K.D. (2006). Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. Bone 38, 749-757.
2. Andersen D.C., Schroder H.D. and Jensen C.H. (2008). Non-cultured adipose-derived. Exp. Cell Res. 314, 2951-2964.
3. Andersen D.C., Petersson S.J., Jorgensen L.H., Bollen P., Jensen P.B., Teisner B., Schroeder H.D. and Jensen, C.H. (2009). Characterization of DLK1+ cells emerging during skeletal muscle remodeling in response to myositis, myopathies, and acute injury. Stem Cells 27, 898-908.
4. Blazejewski S., Le B.B., Boussarie L., Blanc J.F., Malaval L., Okubo K., Saric J., Bioulac-Sage P. and Rosenbaum J. (1997). Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts. Am. J. Pathol. 151, 651-657.
5. Bradshaw A.D., Graves D.C., Motamed K. and Sage E.H. (2003). SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc. Natl. Acad. Sci. USA 100, 6045-6050.
6. Charge S.B. and Rudnicki M.A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238.
7. Chen Y.W., Zhao P., Borup R. and Hoffman E.P. (2000). Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336.
8. Chlenski A., Guerrero L.J., Salwen H.R., Yang Q., Tian Y., Morales La M.A., Mirzoeva S., Bouyer P.G., Xu D., Walker M. and Cohn S.L. (2011). Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone. PLoS One 6, e23880.
9. Cho W.J., Kim E.J., Lee S.J., Kim H.D., Shin H.J. and Lim W.K. (2000). Involvement of SPARC in in vitro differentiation of skeletal myoblasts. Biochem. Biophys. Res. Commun. 271, 630-634.
10. Cornelison D.D. and Wold B.J. (1997). Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191, 270-283.
11. David C., Nance J.P., Hubbard J., Hsu M., Binder D. and Wilson E.H. (2012). Stabilin-1 expression in tumor associated macrophages. Brain Res. 1481, 71-78.
12. Delany A.M., Kalajzic I., Bradshaw A.D., Sage E.H. and Canalis E. (2003). Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology 144, 2588-2596.
13. Dollenmeier P., Turner D.C. and Eppenberger H.M. (1981). Proliferation and differentiation of chick skeletal muscle cells cultured in a chemically defined medium. Exp. Cell Res. 135, 47-61.
14. Ferre P.J., Liaubet L., Concordet D., SanCristobal M., Uro-Coste E., Tosser-Klopp G., Bonnet A., Toutain P.L., Hatey F. and Lefebvre H.P. (2007). Longitudinal analysis of gene expression in porcine skeletal muscle after post-injection local injury. Pharm. Res. 24, 1480-1489.
15. Frizell E., Liu S.L., Abraham A., Ozaki I., Eghbali M., Sage E.H. and Zern M.A. (1995). Expression of SPARC in normal and fibrotic livers. Hepatology 21, 847-854.
16. Fukunaga-Kalabis M. and Herlyn M. (2007). Unraveling mysteries of the multifunctional protein SPARC. J. Invest. Dermatol. 127, 2497-2498.
17. Gilmour D.T., Lyon G.J., Carlton M.B., Sanes J.R., Cunningham J.M., Anderson J.R., Hogan B.L., Evans M.J. and Colledge W.H. (1998). Mice deficient for the secreted glycoprotein SPARC/osteonectin/ BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J. 17, 1860-1870.
18. Goetsch S.C., Hawke T.J., Gallardo T.D., Richardson J.A. and Garry D.J. (2003). Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol. Genomics 14, 261-271.
19. Gooden M.D., Vernon R.B., Bassuk J.A. and Sage E.H. (1999). Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix. J. Cell Biochem. 74, 152-167.
20. Haslett J.N., Sanoudou D., Kho A.T., Bennett R.R., Greenberg S.A., Kohane I.S., Beggs A.H. and Kunkel L.M. (2002). Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl. Acad. Sci. USA 99, 15000-15005.
21. Hellemans J., Mortier G., De P.A., Speleman F. and Vandesompele J. (2007). qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8, R19.
22. Holland P.W., Harper S.J., McVey J.H. and Hogan B.L. (1987). In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J. Cell Biol. 105, 473-482.
23. Jorgensen L.H., Jensen C.H., Wewer U.M. and Schroder H.D. (2007). Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice. Am. J. Pathol. 171, 1599-1607.
24. Jorgensen L.H., Petersson S.J., Sellathurai J., Andersen D.C., Thayssen S., Sant D.J., Jensen C.H. and Schroder H.D. (2009). Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle. J. Histochem. Cytochem. 57, 29-39.
25. Kos K. and Wilding J.P. (2010). SPARC: a key player in the pathologies associated with obesity and diabetes. Nat. Rev. Endocrinol. 6, 225-235.
26. Kos K., Wong S., Tan B., Gummesson A., Jernas M., Franck N., Kerrigan D., Nystrom F.H., Carlsson L.M., Randeva H.S., Pinkney J.H. and Wilding J.P. (2009). Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes 58, 1780-1788.
27. Lane T.F. and Sage E.H. (1994). The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8, 163-173.
28. Lewis M.P., Machell J.R., Hunt N.P., Sinanan A.C. and Tippett H.L. (2001). The extracellular matrix of muscle--implications for manipulation of the craniofacial musculature. Eur. J. Oral Sci. 109, 209-221.
29. Lussier C., Sodek J. and Beaulieu J.F. (2001). Expression of SPARC/osteonectin/BM4O in the human gut: predominance in the stroma of the remodeling distal intestine. J. Cell Biochem. 81, 463-476.
30. Ma P.C., Maulik G., Christensen J. and Salgia R. (2003). c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev. 22, 309-325.
31. Manzur A.Y., Kuntzer T., Pike M. and Swan A. (2008). Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst. Rev. CD003725.
32. Molkentin J.D. and Olson E.N. (1996a). Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93, 9366-9373.
33. Molkentin J.D. and Olson E.N. (1996b). Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 6, 445-453.
34. Motamed K. (1999). SPARC (osteonectin/BM-40). Int. J. Biochem. Cell Biol. 31, 1363-1366.
35. Motamed K., Blake D.J., Angello J.C., Allen B.L., Rapraeger A.C., Hauschka S.D. and Sage E.H. (2003). Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A. J. Cell Biochem. 90, 408-423.
36. Mothe A.J. and Brown I.R. (2001). Differential mRNA expression of the related extracellular matrix glycoproteins SC1 and SPARC in the rat embryonic nervous system and skeletal structure. Brain Res. 892, 27-41.
37. Murphy-Ullrich J.E., Lane T.F., Pallero M.A. and Sage E.H. (1995). SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. J. Cell Biochem. 57, 341-350.
38. Nie J. and Sage E.H. (2009a). SPARC functions as an inhibitor of adipogenesis. J. Cell Commun. Signal. 3, 247-254.
39. Nie J. and Sage E.H. (2009b). SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J. Biol. Chem. 284, 1279-1290.
40. Noguchi S., Tsukahara T., Fujita M., Kurokawa R., Tachikawa M., Toda T., Tsujimoto A., Arahata K. and Nishino I. (2003). cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum. Mol. Genet. 12, 595-600.
41. Porter P.L., Sage E.H., Lane T.F., Funk S.E. and Gown A.M. (1995). Distribution of SPARC in normal and neoplastic human tissue. J. Histochem. Cytochem. 43, 791-800.
42. Purcell L., Gruia-Gray J., Scanga S. and Ringuette M. (1993). Developmental anomalies of Xenopus embryos following microinjection of SPARC antibodies. J. Exp. Zool. 265, 153-164.
43. Reed M.J., Puolakkainen P., Lane T.F., Dickerson D., Bornstein P. and Sage E.H. (1993). Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J. Histochem. Cytochem. 41, 1467-1477.
44. Russell A.P. (2010). Molecular regulation of skeletal muscle mass. Clin. Exp. Pharmacol. Physiol 37, 378-384.
45. Sage H., Vernon R.B., Decker J., Funk S. and Iruela-Arispe M.L. (1989a). Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J. Histochem. Cytochem. 37, 819-829.
46. Sage H., Vernon R.B., Funk S.E., Everitt E.A. and Angello J. (1989b). SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J. Cell Biol. 109, 341-356.
47. Sangaletti S., Tripodo C., Cappetti B., Casalini P., Chiodoni C., Piconese S., Santangelo A., Parenza M., Arioli I., Miotti S. and Colombo M.P. (2011). SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage. Am. J. Pathol. 179, 3000-3010.
48. Schwarzbauer J.E. and Spencer C.S. (1993). The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility. Mol. Biol. Cell 4, 941-952.
49. Seale P. and Rudnicki M.A. (2000). A new look at the origin, function, and stem-cell status of muscle satellite cells. Dev. Biol. 218, 115-124.
50. Shefer G., Wleklinski-Lee M. and Yablonka-Reuveni, Z. (2004). Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J. Cell Sci. 117, 5393-5404.
51. Song H., Guan Y., Zhang L., Li K. and Dong C. (2010). SPARC interacts with AMPK and regulates GLUT4 expression. Biochem. Biophys. Res. Commun. 396, 961-966.
52. Sorokin L.M., Maley M.A., Moch H., von der M.H., von der M.K., Cadalbert L., Karosi S., Davies M.J., McGeachie J.K. and Grounds M.D. (2000). Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury. Exp. Cell Res. 256, 500-514.
53. Vandesompele J., De P.K., Pattyn F., Poppe B., Van R.N., De P.A. and Speleman F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034.
54. Vigna E., Naldini L., Tamagnone L., Longati P., Bardelli A., Maina F., Ponzetto C. and Comoglio P.M. (1994). Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene. Cell Mol. Biol. (Noisy. legrand) 40, 597-604.
55. Workman G. and Sage E.H. (2011). Identification of a sequence in the matricellular protein SPARC that interacts with the scavenger receptor stabilin-1. J. Cell Biochem. 112, 1003-1008.
56. Yan Q., Weaver M., Perdue N. and Sage E.H. (2005). Matricellular protein SPARC is translocated to the nuclei of immortalized murine lens epithelial cells. J. Cell Physiol. 203, 286-294.